Skip to main content
Log in

Overweight or Obesity is an Unfavorable Long-Term Prognostic Factor for Patients who Underwent Gastrectomy for Stage II/III Gastric Cancer

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Obesity has been reported to be a prognostic factor for many diseases in epidemiological studies; however, the results of studies examining the relationship between obesity and gastric cancer (GC) prognosis are inconsistent.

Methods

A total of 460 patients with Stage II and III GC who underwent open R0 gastrectomy were included. Age, sex, body mass index (BMI classified into < 18.5, 18.5–25, and ≥ 25 kg/m2), stage, and postoperative adjuvant chemotherapy were analyzed to investigate the correlation with relapse-free survival (RFS).

Results

Five-year RFS was 51% for the study patients. Five-year RFS values were 47.6%, 54.3%, and 40.1% for patients with BMI < 18.5, 18.5–25, and ≥ 25 kg/m2, respectively. The forest plot for relapse risk according to BMI showed a U shape. Multivariate analysis for RFS showed significant differences in stage and BMI; the hazard ratio for recurrence in patients with BMI ≥ 25 kg/m2 was 1.42 (95% confidence interval: 1.01–2.02, p = 0.0423) with reference to patients with BMI < 25 kg/m2. BMI ≥ 25.0 was associated with longer operation times, more blood loss, fewer lymph nodes dissected, more frequent postoperative surgical site infection, and intra-abdominal abscesses.

Conclusions

BMI ≥ 25 kg/m2 is an unfavorable prognostic factor for patients who underwent gastrectomy for Stage II and III GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Risk Factor Collaboration (NCD-RisC) NCD (2016) Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 387(10026):1377–1396

    Article  Google Scholar 

  2. Prospective Studies Collaboration (2009) Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083–1096

    Article  Google Scholar 

  3. Berrington de Gonzalez A, Hartge P, Cerhan JR (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363:2211–2219

    Article  CAS  Google Scholar 

  4. Zheng W, McLerran DF, Rolland B (2011) Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 364:719–729

    Article  CAS  Google Scholar 

  5. Tao W, Lagergren J (2013) Clinical management of obese patients with cancer. Nat Rev Clin Oncol 10:519–533

    Article  CAS  Google Scholar 

  6. Lavie CJ, Osman AF, Milani RV (2003) Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91:891–894

    Article  Google Scholar 

  7. Adams KF, Schatzkin A, Harris TB (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778

    Article  CAS  Google Scholar 

  8. Mullen JT, Moorman DW, Davenport DL (2009) The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 250:166–172

    Article  Google Scholar 

  9. Yasunaga H, Horiguchi H, Matsuda S (2013) Body mass index and outcomes following gastrointestinal cancer surgery in Japan. Br J Surg 100:1335–1343

    Article  CAS  Google Scholar 

  10. Ferlay J, Soerjomataram I, Dikshit R (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386

    Article  CAS  Google Scholar 

  11. Wu XS, Wu WG, Li ML (2013) Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol 19(28):4596–4606

    Article  Google Scholar 

  12. Voglino C, Di Mare G, Ferrara F (2015) Clinical and oncological value of preoperative BMI in gastric cancer patients: a single center experience. Gastroenterol Res Pract 2015:810134

    Article  Google Scholar 

  13. Wada T, Kunisaki C, Ono HA (2015) Implications of BMI for the prognosis of gastric cancer among the Japanese population. Dig Surg 32(6):480–486

    Article  Google Scholar 

  14. Ejaz A, Spolverato G, Kim Y (2015) Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. J Surg Res 195(1):74–82

    Article  Google Scholar 

  15. Liu BZ, Tao L, Chen YZ (2016) Preoperative body mass index, blood albumin and triglycerides predict survival for patients with gastric cancer. PLoS ONE 11(6):e0157401

    Article  Google Scholar 

  16. Migita K, Takayama T, Matsumoto S (2016) Impact of being underweight on the long-term outcomes of patients with gastric cancer. Gastric Cancer 19(3):735–743

    Article  Google Scholar 

  17. Jun DH, Kim BJ, Park JH (2016) Preoperative body mass index may determine the prognosis of advanced gastric cancer. Nutr Cancer 68(8):1295–1300

    Article  CAS  Google Scholar 

  18. Japanese Gastric Cancer Association (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20(1):1–19

    Article  Google Scholar 

  19. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163

    Article  Google Scholar 

  20. Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2):101–112

    Article  Google Scholar 

  21. Jiang X, Hiki N, Nunobe S (2012) Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107(2):275–279

    Article  CAS  Google Scholar 

  22. Murakami Y, Saito H, Kono Y (2018) Combined analysis of the preoperative and postoperative prognostic nutritional index offers a precise predictor of the prognosis of patients with gastric cancer. Surg Today 48(4):395–403

    Article  Google Scholar 

  23. Kuroda D, Sawayama H, Kurashige J (2018) Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer 21(2):204–212

    Article  Google Scholar 

  24. Gunderson CC, Java J, Moore KN (2014) The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol 133(1):23–27

    Article  Google Scholar 

  25. Steffens S, Ringe KI, Schroeer K (2013) Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study. Int J Urol 20(6):585–592

    Article  Google Scholar 

  26. Tokunaga M, Hiki N, Fukunaga T (2009) Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol 16:3245–3251

    Article  Google Scholar 

  27. Chen HN, Chen XZ, Zhang WH (2015) The impact of body mass index on the surgical outcomes of patients with gastric cancer A 10-year, single-institution cohort study. Medicine 94(42):e1769

    Article  Google Scholar 

  28. Kulig J, Sierzega M, Kolodziejczyk P (2010) Implications of overweight in gastric cancer: a multicenter study in a Western patient population. Eur J Surg Oncol 36:969–976

    Article  CAS  Google Scholar 

  29. Lin YS, Huang KH, Lan YT (2013) Impact of body mass index on postoperative outcome of advanced gastric cancer after curative surgery. J Gastrointest Surg 17:1382–1391

    Article  Google Scholar 

  30. Wong J, Rahman S, Saeed N (2014) Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg 18:505–511

    Article  Google Scholar 

  31. Ejaz A, Spolverato G, Kim Y (2015) Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. J Surg Res 195:74–82

    Article  Google Scholar 

  32. Wu XS, Wu WG, Li ML (2013) Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol 19:4596–4606

    Article  Google Scholar 

  33. Wu XS, Wu WG, Li ML (2013) Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol 19:4596–4606

    Article  Google Scholar 

  34. Bickenbach KA, Denton B, Gonen M (2013) Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol 20(3):780–787

    Article  Google Scholar 

  35. Struecker B, Biebl M, Dadras M (2017) The impact of obesity on outcomes following resection for gastric cancer. Dig Surg 34(2):133–141

    Article  Google Scholar 

  36. Tanaka K, Miyashiro I, Yano M (2009) Accumulation of excess visceral fat is a risk factor for pancreatic fistula formation after total gastrectomy. Ann Surg Oncol 16(6):1520–1525

    Article  Google Scholar 

  37. Sugisawa N, Tokunaga M, Tanizawa Y (2012) Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer 15(2):206–212

    Article  Google Scholar 

  38. Takeuchi M, Ishii K, Seki H (2016) Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study. BMC Surg 16(1):54

    Article  Google Scholar 

  39. Sorensen LT, Hemmingsen U, Kallehave F (2005) Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg 241:654–658

    Article  Google Scholar 

  40. Brem H, Tomic-Canic M (2007) Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117:1219–1222

    Article  CAS  Google Scholar 

  41. Goldfarb Y, Sorski L, Benish M (2011) Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 253:798–810

    Article  Google Scholar 

  42. Hayashi T, Yoshikawa T, Aoyama T (2015) Impact of infectious complications on gastric cancer recurrence. Gastric Cancer 18(2):368–374

    Article  Google Scholar 

  43. Fujiya K, Tokunaga M, Mori K (2016) Long-term survival in patients with postoperative intra-abdominal infectious complications after curative gastrectomy for gastric cancer: a propensity score matching analysis. Ann Surg Oncol 23(Suppl 5):809–816

    Article  Google Scholar 

  44. Vuong B, Graff-Baker AN, Dehal A (2017) Survival analysis with extended lymphadenectomy for gastric cancer: removing stage migration from the equation. Am Surg 83(10):1074–1079

    PubMed  Google Scholar 

  45. Biondi A, D’Ugo D, Cananzi FC (2015) Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Eur J Surg Oncol 41(6):779–786

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuichi Kambara.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kambara, Y., Yuasa, N., Takeuchi, E. et al. Overweight or Obesity is an Unfavorable Long-Term Prognostic Factor for Patients who Underwent Gastrectomy for Stage II/III Gastric Cancer. World J Surg 43, 1766–1776 (2019). https://doi.org/10.1007/s00268-019-04969-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-019-04969-1

Navigation